Stephen J. Schuster

faculty photo
Robert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research
Attending Physician, Department of Medicine, Division of Hematology-Oncology, Hospital of the University of Pennsylvania
Director, Lymphoma Translational Research, Abramson Cancer Center of the University of Pennsylvania
Department: Medicine

Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-157
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: (215) 614-1846
Fax: 215-615-5888
Education:
B.S. (Psychology)
Saint Joseph's University, Philadelphia, PA, 1976.

Laboratory Research Technician, Division of Rheumatology, Hahnemann Medical College and Hospital, Philadelphia, PA, 1977.
M.D.
Jefferson Medical College, Philadelphia, PA, 1981.
Permanent link
 

Description of Itmat Expertise

Application of immunology to therapeutic approaches for lymphomas and chronic lymphocytic leukemia. Imaging of lymphomas and chronic lymphocytic leukemia.

Selected Publications

Salles, Gilles. Schuster, Stephen J. de Vos, Sven. Wagner-Johnston, Nina D. Viardot, Andreas. Blum, Kristie A. Flowers, Christopher R. Jurczak, Wojciech J. Flinn, Ian W. Kahl, Brad S. Martin, Peter. Kim, Yeonhee. Shreay, Sanatan. Will, Matthias. Sorensen, Bess. Breuleux, Madlaina. Zinzani, Pier Luigi. Gopal, Ajay K.: Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study. Haematologica. Dec 15 2016 Notes: [Epub ahead of print]

Chong, Elise A. Melenhorst, J Joseph. Lacey, Simon F. Ambrose, David E. Gonzalez, Vanessa. Levine, Bruce. June, Carl H. Schuster, Stephen J. : PD-1 Blockade Modulates Chimeric Antigen Receptor (CAR) Modified T Cells and Induces Tumor Regression: Refueling the CAR. Blood. Dec 28 2016 Notes: [Epub ahead of print]

Mato, Anthony R. Nabhan, Chadi. Barr, Paul M. Ujjani, Chaitra S. Hill, Brian T. Lamanna, Nicole. Skarbnik, Alan P. Howlett, Christina. Pu, Jeffrey J. Sehgal, Alison R. Strelec, Lauren E. Vandegrift, Alexandra. Fitzpatrick, Danielle M. Zent, Clive S. Feldman, Tatyana. Goy, Andre. Claxton, David F. Bachow, Spencer Henick. Kaur, Gurbakhash. Svoboda, Jakub. Nasta, Sunita Dwivedy. Porter, David. Landsburg, Daniel J. Schuster, Stephen J. Cheson, Bruce D. Kiselev, Pavel. Evens,Andrew M.: Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience. Blood. 128(18): 2199-2205, Nov 3 2016.

Wang, Jie. Morrissette, Jennifer. Lieberman, David B. Timlin, Colleen. Schuster, Stephen J. Mato, Anthony R.: Utilization of next generation sequencing identifies potentially actionable mutations in chronic lymphocytic leukaemia. British Journal of Haematology. Oct 7 2016 Notes: [Epub ahead of print]

Lesokhin, Alexander M. Ansell, Stephen M. Armand, Philippe. Scott, Emma C. Halwani, Ahmad. Gutierrez, Martin. Millenson, Michael M. Cohen, Adam D. Schuster, Stephen J. Lebovic, Daniel. Dhodapkar, Madhav. Avigan, David. Chapuy, Bjoern. Ligon, Azra H. Freeman, Gordon J. Rodig, Scott J. Cattry, Deepika. Zhu, Lili. Grosso, Joseph F. Bradley Garelik, M Brigid. Shipp, Margaret A. Borrello, Ivan. Timmerman, John.: Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study. Journal of Clinical Oncology. 34(23): 2698-704, Aug 10 2016.

Yam, Clinton. Landsburg, Daniel J. Nead, Kevin T. Lin, Xinyi. Mato, Anthony R. Svoboda, Jakub. Loren, Alison W. Frey, Noelle V. Stadtmauer, Edward A. Porter, David L. Schuster, Stephen J. Nasta, Sunita D.: Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas. American Journal of Hematology. 91(7): 672-6, Jul 2016.

Ruella, Marco. Kenderian, Saad S. Shestova, Olga. Fraietta, Joseph A. Qayyum, Sohail. Zhang, Qian. Maus, Marcela V. Liu, Xiaobin. Nunez-Cruz, Selene. Klichinsky, Michael. Kawalekar, Omkar U. Milone, Michael. Lacey, Simon F. Mato, Anthony. Schuster, Stephen J. Kalos, Michael. June, Carl H. Gill1, Saar. Wasik, Mariusz A. : The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma. Clinical Cancer Research. 22(11): 2684-96, Jun 1 2016.

Ruella, Marco. Kenderian, Saad S. Shestova, Olga. Fraietta, Joseph A. Qayyum, Sohail. Zhang, Qian. Maus, Marcela V. Liu, Xiaobin. Nunez-Cruz, Selene. Klichinsky, Michael. Kawalekar, Omkar U. Milone, Michael. Lacey, Simon F. Mato, Anthony. Schuster, Stephen J. Kalos, Michael. June, Carl H. Gill, Saar. Wasik, Mariusz A.: The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma. Clinical Cancer Research. 22(11): 2684-96, Jun 2016.

Williams, Michael E. Hong, Fangxin. Gascoyne, Randy D. Wagner, Lynne I. Krauss, John C. Habermann, Thomas M. Swinnen, Lode J. Schuster, Stephen J. Peterson, Christopher G. Sborov, Mark D. Martin, S Eric. Weiss, Matthias. Ehmann, W Christopher. Horning, Sandra J. Kahl, Brad S.: Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402. British Journal of Hematology. 173(6): 867-75, Jun 2016.

Williams, Michael E. Hong, Fangxin. Gascoyne, Randy D. Wagner, Lynne I. Krauss, John C. Habermann, Thomas M. Swinnen, Lode J. Schuster, Stephen J. Peterson, Christopher G. Sborov, Mark D. Martin, Eric. Weiss, Matthias. Ehmann, W. Christopher. Horning, Sandra J. Kahl, Brad S. : Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402. British Journal of Haematology. Mar 11 2016 Notes: [Epub ahead of print]

back to top
Last updated: 02/15/2017
The Trustees of the University of Pennsylvania